Citation Impact
Citing Papers
Cognitive and emotional influences in anterior cingulate cortex
2000 Standout
Progression of parkinsonism in multiple system atrophy
2005
Systematic evaluation of rating scales for impairment and disability in Parkinson's disease
2002
Neurophysiological characterization of parkinsonian syndromes
2000
Differential clinical and motor control function in a pair of monozygotic twins with Huntington's disease
1999
Mechanisms and Functional Implications of Adult Neurogenesis
2008 Standout
Getting Formal with Dopamine and Reward
2002 Standout
Treatment of Parkinson's disease
2000
Structural basis for triplet repeat disorders: a computational analysis
1999 StandoutNobel
Clinical course of patients with idiopathic Parkinson's disease
1996
Huntington's disease
2007 Standout
Transplantation in Parkinson’s Disease
2007
The Sydney multicentre study of Parkinson's disease: progression and mortality at 10 years
1999
Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration
1997
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
2015 Standout
Vascular Parkinsonism: A Clinical Review
2008
Leber's hereditary optic neuropathy (LHON/11778) with myoclonus: report of two cases
2001
Parkinson's disease: clinical features and diagnosis
2008 Standout
Staging of brain pathology related to sporadic Parkinson’s disease
2002 Standout
Coding and use of tactile signals from the fingertips in object manipulation tasks
2009 Standout
Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS)
2004
Subthalamic nucleus deep brain stimulation: Summary and meta-analysis of outcomes
2006 Standout
Phenotypic characterisation of autosomal recessive PARK6‐linked parkinsonism in three unrelated Italian families
2001
Huntington’s disease
2006
Voxel-based morphometry in autopsy proven PSP and CBD
2006
Neurodegenerative Diseases Target Large-Scale Human Brain Networks
2009 Standout
Epidemiology of Parkinson's disease
2006 Standout
THROUGH A LOOKING GLASS. A NEW TECHNIQUE TO DEMONSTRATE DIRECTIONAL HYPOKINESIA IN UNILATERAL NEGLECT
1991
Patterns of Outcome Measurement in Parkinson’s Disease Clinical Trials
2000
Role of α-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice
2003 StandoutNobel
Clinical and Pathological Aspects of Parkinsonism in Alzheimer's Disease
1989
Parkinson's disease
2009 Standout
Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus)
1997
Clinical and molecular advances in autosomal dominant cerebellar ataxias: from genotype to phenotype and physiopathology
2000
Nerve cell loss in the thalamic mediodorsal nucleus in Huntington's disease
1999
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
2001 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
What Is the Accuracy of the Clinical Diagnosis of Multiple System Atrophy?
1997
The impact of deep brain stimulation on executive function in Parkinson's disease
2000
Psychotic symptoms in Parkinson’s disease
2005
Parkinson Disease Neuropathology
2002
Unilateral Transplantation of Human Fetal Mesencephalic Tissue into the Caudate Nucleus of Patients with Parkinson's Disease
1992
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
2016 Standout
Alzheimer's Disease and Parkinson's Disease
2003
A model of saccade generation based on parallel processing and competitive inhibition
1999
Protein aggregation and neurodegenerative disease
2004 Standout
High‐field magnetic resonance imaging of brain iron: birth of a biomarker?
2004
Components of neglect from right-hemisphere damage: An analysis of line bisection
1990
Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy
2006
Striatal deformities of the hand and foot in Parkinson's disease
2005
Non‐motor behavioural impairments in parkin‐deficient mice
2007
A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or Levodopa
2000 Standout
Parkinson's disease
2015 Standout
Impaired visual search in patients with unilateral neglect: an oculographic analysis
1997
Interrater reliability of the unified Parkinson's disease rating scale motor examination
1994
SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders
2003
Consensus statement on the diagnosis of multiple system atrophy
1998
Replicating Huntington's disease phenotype in experimental animals
1999
Five-Year Follow-up of Bilateral Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
2003 Standout
Protective Effect of Spermidine Against Excitotoxic Neuronal Death Induced by Quinolinic Acid in Rats: Possible Neurotransmitters and Neuroinflammatory Mechanism
2015
Multiple system atrophy: A review of 203 pathologically proven cases
1997
Eye movements in reading and information processing: 20 years of research.
1998 Standout
Striatonigral Degeneration: Iron Deposition in Putamen Correlates with the Slit-like Void Signal of Magnetic Resonance Imaging
1994
Treatment interventions for Parkinson's disease: an evidence based assessment
2002
Vigabatrin
1991
Methods in Mammalian Autophagy Research
2010 Standout
Saccadic eye movement programming in unilateral neglect
1996
Control and interference in task switching—A review.
2010 Standout
Dopamine depletion impairs precursor cell proliferation in Parkinson disease
2004
Parkinson Disease Survival
2000
Parkinson's Disease
1998 Standout
Clinical outcomes of progressive supranuclear palsy and multiple system atrophy
2008
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease
2004 Standout
Non-motor features of Parkinson disease
2017 Standout
Apraxia in movement disorders
2005
Decreased striatal monoaminergic terminals in multiple system atrophy detected with positron emission tomography
1999
Coordination of Prehensile Forces during Precision Grip in Huntington's Disease
2000
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Memory for temporal order and conditional associative-learning in patients with Parkinson's disease
1990
Patterns of Brain Atrophy That Differentiate Corticobasal Degeneration Syndrome From Progressive Supranuclear Palsy
2006
Huntington's Disease and Related Disorders
2005
Neurodegenerative diseases and oxidative stress
2004 Standout
Dopamine in Motivational Control: Rewarding, Aversive, and Alerting
2010 Standout
The diagnosis of Parkinson's disease
2005
Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?
1997
Dementia associated with Parkinson's disease
2003
Impaired self-initiated task preparation during task switching in Parkinson's disease
2006
Neural Mechanisms of Selective Visual Attention
1995 Standout
Molecular Mechanisms of Amyloidosis
2003 Standout
The Neuropathology of Huntington’s Disease
2014
Consensus statement on the diagnosis of multiple system atrophy
1999
Unified Parkinson's disease rating scale characteristics and structure
1994
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Parkinson's Disease
2003 Standout
Animal Models of Parkinsonism Using Selective Neurotoxins: Clinical and Basic Implications
1989
Levodopa-Induced Neurotoxicity
1997
Role of the Basal Ganglia in the Control of Purposive Saccadic Eye Movements
2000
The functional anatomy of basal ganglia disorders
1989 Standout
Huntington??s Disease
1999
A PET study of visuospatial attention
1993 Standout
Patient-reported autonomic symptoms in Parkinson disease
2007
Saccades in Huntington's disease
1988
The Neuroanatomy and Neurophysiology of Attention
1991
Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease
2000 Standout
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
1992 Standout
Behavior in Huntington's Disease
2002
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
MDS clinical diagnostic criteria for Parkinson's disease
2015 Standout
Predictive Reward Signal of Dopamine Neurons
1998 Standout
Spermidine in health and disease
2018 StandoutScience
Long oligonucleotide microarrays for African green monkey gene expression profile analysis
2007 StandoutNobel
Abnormal ocular motor control in Huntington's disease
1983
Small molecule regulators of autophagy identified by an image-based high-throughput screen
2007
Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex
1986 Standout
Mortality and Parkinson disease
2004
Multiple system atrophy presenting as parkinsonism: clinical features and diagnostic criteria.
1995
The association of incident dementia with mortality in PD
2002
Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT.
1994
Clinical usefulness of magnetic resonance imaging in multiple system atrophy
1998
Second consensus statement on the diagnosis of multiple system atrophy
2008 Standout
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
Metals in Neurobiology: Probing Their Chemistry and Biology with Molecular Imaging
2008 Standout
A polymorphic DNA marker genetically linked to Huntington's disease
1983 StandoutNature
Neurotransmitters in Huntington's Chorea—a Clinician's View
1982
Asymmetric Transition-Metal-Catalyzed Allylic Alkylations: Applications in Total Synthesis
2003 Standout
Diffusion tensor imaging in parkinsonian syndromes
2013
Works of F. Girotti being referenced
Intrathecal immune activation in three patients with progressive myoclonic ataxia
1995
Clinical and Magnetic Resonance Features of the Classic and Akinetic-Rigid Variants of Huntington's Disease
1993
Variations in Axial, Proximal, and Distal Motor Response to L-Dopa in Multisystem Atrophy and Parkinsonʼs Disease
1997
Multiple system atrophy. Clinical and MR observations on 42 cases
1993
Relationship between motor and cognitive disorders in Huntington's disease
1988
Psychiatric Symptoms Do Not Correlate With Cognitive Decline, Motor Symptoms, or CAG Repeat Length in Huntington's Disease
1996
Olivopontocerebellar atrophy: MR diagnosis and relationship to multisystem atrophy.
1990
MR Imaging in Progressive Supranuclear Palsy and Shy-Drager Syndrome
1989
Response to L-DOPA in Multiple System Atrophy
1993
Affective symptoms in multiple system atrophy and Parkinson's disease: response to levodopa therapy
1999
Adult onset myoclonic Huntington's disease
1993
Diffusion Tensor Imaging Shows Different Topographic Involvement of the Thalamus in Progressive Supranuclear Palsy and Corticobasal Degeneration
2009
Interobserver reliability between neurologists in training of Parkinson's disease rating scales. A multicenter study
1991
Clinical and molecular studies of 73 Italian families with autosomal dominant cerebellar ataxia type I: SCA1 and SCA2 are the most common genotypes
1999
Effect of bilateral subthalamic electrical stimulation in Parkinson’s disease
2001
Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders
1994
Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy
2001
Cognitive Dysfunction and Impaired Organization of Complex Motility in Degenerative Parkinsonian Syndromes
1998
Neurophysiological features in relation to clinical signs in clinically diagnosed corticobasal degeneration
2003
Early‐onset Parkinson's disease
1991
Dystonia and Parkinson's disease.
1993
Motor and cognitive performances of parkinsonian patients in the on and off phases of the disease.
1986
Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy
1999
Reduced Risk Factors for Vascular Disorders in Parkinson Disease Patients
2006
Magnetic resonance imaging in CBD, related atypical parkinsonian disorders, and dementias.
2000
Effects of DA agonist in Huntington disease hyperkinesia
1979
Oculomotor disorders in cortical lesions in man: The role of unilateral neglect
1983
Biochemical aspects of Huntington's chorea.
1977
Pharmacology of Huntington’s Chorea
1977
Abnormal MRI signal in the rigid form of Huntington's disease.
1991
Depression in Parkinson's disease. An update.
2001
2-Dimethylaminoethanol (Deanol) in Huntington's chorea
1978
Double‐blind study of oral γ‐vinyl GABA in the treatment of dystonia
1986
Limb apraxia in corticobasal degeneration and progressive supranuclear palsy
2005
Study of the Excitability Cycle of the Blink Reflex in Huntington’s Chorea
1976
L‐dopa long‐term treatment in Parkinson's disease
1983
Gamma‐vinyl GABA treatment of Huntington's disease
1984
Effect of neuroleptic treatment on involuntary movements and motor performances in Huntington's disease.
1984
Role of motor performance in cognitive processes of parkinsonian patients
1988
Possible involvement of attention processes in Parkinson's disease.
1987
Dementia and cognitive impairment in Parkinson's disease.
1988
Oculomotor disorders in Huntington's chorea.
1979
Mortality associated with early and late levodopa therapy initiation in Parkinson's disease
1990